What You Should Know
- The Announcement: Mayo Clinic Platform_Accelerate has officially welcomed its newest cohort, selecting 18 national and international healthcare technology companies to participate in its 30-week immersive program.
- The “Moat”: The most significant benefit of the program is access to Mayo Clinic’s data ecosystem. Startups will be able to utilize millions of de-identified, longitudinal clinical records to develop, train, and validate their artificial intelligence (AI) models.
- The Clinical Scope: The 18 selected companies cover a massive swath of clinical and operational needs, ranging from genomic cancer diagnostics and rare disease therapies to AI-powered surgical navigation and GLP-1 obesity care management.
The Cohort: From the Front Desk to the Operating Room
For 30 weeks, these startups will not only receive expert mentorship from Mayo Clinic clinicians, but they will also be granted the golden ticket of health-tech: access to millions of de-identified, longitudinal clinical records to validate and refine their AI-driven solutions.
The selected companies highlight the industry’s shift away from generic AI chatbots and toward highly specialized, multimodal clinical applications. The 18 startups can be broadly categorized into several key domains:
1. Precision Medicine & Oncology
- Curenetics: A U.K.-based company integrating clinical, genomic, and imaging data to predict how individual patients will respond to cancer immunotherapy.
- Xcoo: Provides an AI-powered service (Chrovis) that supports genomic cancer diagnosis and treatment decisions.
- Ecotone AI: Applies frontier AI and full-genome analysis to uncover disease-driving genetic mechanisms for rare diseases.
2. Surgical Intelligence & Acute Care
- Precision Imaging Inc: A Tokyo-based medtech startup using computer vision for high-precision, intraoperative navigation in orthopedic surgeries (starting with hip arthroplasty).
- Bluevia Health: An applied AI platform that analyzes multimodal clinical data to detect postoperative deterioration earlier.
- Hoopcare: Automates preoperative evaluations and predicts postoperative complications to reduce surgical risk.
- NeoCure Inc: Analyzes bedside vital data to detect eye diseases in preterm infants without requiring an on-site specialist.
3. Chronic Care, GLP-1s & Fertility
- EW2Health: Uses predictive behavioral analytics to forecast weight trends and enable proactive interventions for patients utilizing GLP-1 therapies.
- Canary Applied Intelligence: Identifies high-risk patients in cardio-renal care to enable proactive interventions.
- YOBO Health: A care coordination platform designed to prevent hospital readmissions for cardio-renal-metabolic conditions.
- Hera: Combines testing with predictive analytics to deliver personalized sperm health insights for male fertility.
- OneMedic: A Vietnam-based primary care ecosystem using AI for early detection and management of chronic diseases.
- NousLogic Telehealth: A remote elderly patient monitoring platform that tracks vital signs and includes AI-based medication dispensing.
- MyBackHub: Uses AI to triage and guide personalized, nonoperative back pain care.
4. Administrative & Operational Automation
- 100ms: Builds AI agents that automate patient access workflows for specialty practices.
- SPRYT: Develops “Asa,” an AI medical receptionist that empowers patients to book and pay for appointments via text in their preferred language.
- Avedian: Delivers operational insights to help health systems improve efficiency and capacity planning.
- Cura AI: Unifies fragmented data into a portable, patient-owned record to support early-risk detection.
“The innovation we’re seeing in this February cohort is a testament to the accelerating pace of AI in medicine,” said Jamie Sundsbak, director of the Accelerate program. “We are proud to support these 18 companies as they transition from revolutionary concepts to scalable solutions that can help define the next decade of healthcare.”
